DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals
DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals
Introduction: pancreatic cancer (PC) is the fifth leading cause of cancer-related death in the UK. The incidence of PC is increasing, with little or no improvement in overall survival and the best chance for long-term survival in patients with PC relies on early detection and surgical resection. In this study, we propose the use of a diagnostic algorithm that combines tests of pancreatic exocrine function (faecal elastase-1 (FE-1) test and the 13C-mixed triglyceride (13C-MTG) breath test) to identify patients with PC that urgently needs imaging studies.
Methods and analysis: this prospective pilot (proof of concept) study will be carried out on 25 patients with resectable PC, 10 patients with chronic pancreatitis and 25 healthy volunteers. This study will construct a predictive algorithm for PC, using two tests of pancreatic exocrine function, FE-1 test and the 13C-MTG breath test. Continuous flow isotope ratio mass spectrometry in the 13C-MTG breath test will be used to analyse enriched 13CO2 in exhaled breath samples. The additional predictive benefit of other potential biomarkers of PC will also be considered. Potential biomarkers of PC showing abilities to discriminate between patients with PC from healthy subjects or patients with chronic pancreatitis will be selected by metabolomic analysis.
Ethics and dissemination: the study was approved by the North of Scotland Research and Ethics Committee on 1 October 2020 (reference: 20/NS/0105, favourable opinion granted). The results will be disseminated in presentations at academic national/international conferences and publication in peer-review journals.
biochemistry, endocrine tumours, gastrointestinal tumours, pancreatic disease, pancreatic surgery
Afolabi, Paul Remi
757e7f01-664c-493e-bc51-c6a2c933dc22
McDonnell, Declan
b7499481-73e7-4130-897e-cd4200c8a43b
Byrne, Christopher D
1370b997-cead-4229-83a7-53301ed2a43c
Wilding, Sam
1f316b8b-db59-4289-b6aa-183f957f3470
Goss, Victoria
ef02be5d-9318-4f7d-b076-3153555980d0
Walters, Jocelyn
a9041dd0-b700-4182-98ce-f02b73f15d5a
Hamady, Zaed Z
545a1c81-276e-4341-a420-aa10aa5d8ca8
25 February 2022
Afolabi, Paul Remi
757e7f01-664c-493e-bc51-c6a2c933dc22
McDonnell, Declan
b7499481-73e7-4130-897e-cd4200c8a43b
Byrne, Christopher D
1370b997-cead-4229-83a7-53301ed2a43c
Wilding, Sam
1f316b8b-db59-4289-b6aa-183f957f3470
Goss, Victoria
ef02be5d-9318-4f7d-b076-3153555980d0
Walters, Jocelyn
a9041dd0-b700-4182-98ce-f02b73f15d5a
Hamady, Zaed Z
545a1c81-276e-4341-a420-aa10aa5d8ca8
Afolabi, Paul Remi, McDonnell, Declan, Byrne, Christopher D, Wilding, Sam, Goss, Victoria, Walters, Jocelyn and Hamady, Zaed Z
(2022)
DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals.
BMJ Open, 12 (2), [e057271].
(doi:10.1136/bmjopen-2021-057271).
Abstract
Introduction: pancreatic cancer (PC) is the fifth leading cause of cancer-related death in the UK. The incidence of PC is increasing, with little or no improvement in overall survival and the best chance for long-term survival in patients with PC relies on early detection and surgical resection. In this study, we propose the use of a diagnostic algorithm that combines tests of pancreatic exocrine function (faecal elastase-1 (FE-1) test and the 13C-mixed triglyceride (13C-MTG) breath test) to identify patients with PC that urgently needs imaging studies.
Methods and analysis: this prospective pilot (proof of concept) study will be carried out on 25 patients with resectable PC, 10 patients with chronic pancreatitis and 25 healthy volunteers. This study will construct a predictive algorithm for PC, using two tests of pancreatic exocrine function, FE-1 test and the 13C-MTG breath test. Continuous flow isotope ratio mass spectrometry in the 13C-MTG breath test will be used to analyse enriched 13CO2 in exhaled breath samples. The additional predictive benefit of other potential biomarkers of PC will also be considered. Potential biomarkers of PC showing abilities to discriminate between patients with PC from healthy subjects or patients with chronic pancreatitis will be selected by metabolomic analysis.
Ethics and dissemination: the study was approved by the North of Scotland Research and Ethics Committee on 1 October 2020 (reference: 20/NS/0105, favourable opinion granted). The results will be disseminated in presentations at academic national/international conferences and publication in peer-review journals.
Text
e057271.full
- Version of Record
More information
Accepted/In Press date: 7 February 2022
Published date: 25 February 2022
Keywords:
biochemistry, endocrine tumours, gastrointestinal tumours, pancreatic disease, pancreatic surgery
Identifiers
Local EPrints ID: 455756
URI: http://eprints.soton.ac.uk/id/eprint/455756
ISSN: 2044-6055
PURE UUID: fcef916f-c630-421c-a108-794c4da584d9
Catalogue record
Date deposited: 01 Apr 2022 18:27
Last modified: 20 Jun 2024 01:57
Export record
Altmetrics
Contributors
Author:
Paul Remi Afolabi
Author:
Declan McDonnell
Author:
Sam Wilding
Author:
Victoria Goss
Author:
Jocelyn Walters
Author:
Zaed Z Hamady
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics